Ixabepilone

Back to search

Molecule Structure

Scientific Name

Ixabepilone

Description of the Drug

Ixabepilone is a microtubule inhibitor administered in combination with capecitabine or alone in the treatment of metastatic or locally advanced breast cancer that has shown inadequate response to taxanes and anthracyclines.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-02-07 from
http://www.drugbank.ca/drugs/DB04845

Brand Name(s)

Ixempra, Ixempra kit

Company Owner(s)

R-Pharm Us Llc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Tubulin PROTEIN COMPLEX GROUP INHIBITOR CHEMBL2095182

Unichem Links

SureChEMBL SCHEMBL8386
DrugBank DB04845
PubChem: Thomson Pharma 14786763 14933557
PubChem 6445540
LINCS LSM-43293
Nikkaji J1.408.120H
PDBe GZX
EPA CompTox Dashboard DTXSID70870252
DrugCentral 1517
ChemicalBook CB61011739
Guide to Pharmacology 6824
GSRS 61d41896-027e-4aeb-9265-9787069acccd
rxnorm IXABEPILONE IXEMPRA
PubChem: Drugs of the Future 49684213
ChEBI 63605
ZINC ZINC000003993846